Legal wrangle puts India's generic drugs at risk - Novartis is trying to influence patent legislation in India to prevent the production of generics. This would affect millions of Africans suffering from AIDS, as the costs for the necessary medicines would suddenly skyrocket. Profit before human lives, that is the motto of the pharmaceutical industry.